Stryker Corp. (SYK)

Stryker Corp. (SYK) remains a dominant player in the orthopedic sector, particularly in hips and knees procedures. Despite facing challenges such as a cybersecurity incident and the general weakness in the health sector, the company is expected to rebound and regain market share due to its strong relationships with medical professionals and a solid track record in medtech. Analysts predict continued growth, especially with robotic-assisted surgeries becoming a key driver of its orthopedic business. While the recent performance has been weaker post-Covid, many experts note the stock's attractive valuation and potential for revenue growth, supported by an aging population and a trend toward surgical intervention. There is a consensus that Stryker's performance prospects remain positive, making it a long-term investment option.